Market News AIOpen the app

EPRX stock news · Eupraxia Pharmaceuticals Inc.

Stories about Eupraxia Pharmaceuticals Inc. (EPRX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for EPRX

Follow Eupraxia Pharmaceuticals Inc. (EPRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for EPRX
Free on the App Store and Google Play, or on the web.
  1. Nov 11, 2026, 9:08 AM ET · Market

    Eupraxia Pharmaceuticals lost $15.2 million last quarter, up from $6.4 million a year earlier, mainly because of rising research costs.

    Neutral

    Eupraxia's loss grew from $6.4 million to $15.2 million. Cash and investments are expected to fund operations into the second half of 2028, leaving a mixed outlook.